Radiation Therapy + Chemotherapy for Stage T1 Bladder Cancer (UW 7684/RTOG 0926)
RTOG 0926 A Phase II Protocol For Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging.
Investigator: George Laramore, MD, PhD; Conditions: Bladder Cancer; Status: Recruiting; Study ID: NCT00981656
A Phase 1-2 Study of Rapamycin (Sirolimus) and Cisplatin/Gemcitabine for Treatment of Patients With Bladder Cancer
Investigator: Bruce Montgomery, MD; Conditions: Bladder Cancer; Status: Recruiting; Study ID: NCT01938573
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer
Investigator: Evan Ya-Wen Yu, MD; Conditions: Metastatic Urothelial Cancer; Status: Recruiting; Study ID: NCT01963052